- Report
- April 2022
- 302 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- February 2024
- 255 Pages
Global
From €4534EUR$4,950USD£3,854GBP
- Report
- May 2023
- 244 Pages
Global
From €2519EUR$2,750USD£2,141GBP
€5038EUR$5,500USD£4,282GBP
- Report
- June 2022
- 283 Pages
United States
From €2405EUR$2,625USD£2,044GBP
€4809EUR$5,250USD£4,087GBP
- Report
- May 2022
- 263 Pages
Global
From €2405EUR$2,625USD£2,044GBP
€4809EUR$5,250USD£4,087GBP
- Report
- May 2022
- 170 Pages
Middle East
From €2405EUR$2,625USD£2,044GBP
€4809EUR$5,250USD£4,087GBP
- Report
- March 2021
- 279 Pages
Global
From €2290EUR$2,500USD£1,946GBP
€4580EUR$5,000USD£3,893GBP
- Report
- November 2022
- 155 Pages
Global
From €2061EUR$2,250USD£1,752GBP
- Report
- June 2023
- 186 Pages
Global
From €2982EUR$3,255USD£2,534GBP
€4260EUR$4,650USD£3,620GBP
- Report
- April 2023
- 135 Pages
Global
From €1603EUR$1,750USD£1,362GBP
€2290EUR$2,500USD£1,946GBP
- Report
- February 2023
- 287 Pages
Global
From €1603EUR$1,750USD£1,362GBP
€2290EUR$2,500USD£1,946GBP
- Report
- December 2022
- 93 Pages
Global
From €3527EUR$3,850USD£2,997GBP
€5038EUR$5,500USD£4,282GBP
- Report
- February 2022
- 157 Pages
Global
From €3527EUR$3,850USD£2,997GBP
€5038EUR$5,500USD£4,282GBP
- Report
- March 2021
- 216 Pages
Global
From €1763EUR$1,925USD£1,499GBP
€2519EUR$2,750USD£2,141GBP
- Report
- October 2019
- 72 Pages
Global
From €1266EUR$1,383USD£1,076GBP
€1809EUR$1,975USD£1,538GBP
- Report
- May 2019
- 140 Pages
Global
From €1763EUR$1,925USD£1,499GBP
€2519EUR$2,750USD£2,141GBP
- Report
- September 2023
- 270 Pages
Global
From €3825EUR$4,175USD£3,250GBP
- Report
- April 2024
- 100 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- October 2023
- 195 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- October 2023
- 120 Pages
Global
From €5451EUR$5,950USD£4,632GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more